Scientific Advisory Board
Global Genomics Group is guided by a panel of experts on our Scientific Advisory Board, including:
Mario Alberto Accardi, Ph.D.; CEO and Co-founder of Orthonika, Partner at venture capital fund Fort Rock Capital and Visiting Researcher at Imperial College London
Aruna Bansal, MSc, Ph.D., CStat, CSci; Acclarogen Ltd, St John’s Innovation Centre, UK.
Michael R. Barnes, Ph.D.;Director of Bioinformatics, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, John Vane Science Centre, UK.
Brett R. Blackman, Ph.D.; Visiting Associate Professor of Biomedical Engineering, University of Virginia; Chief Scientific Officer & Co-Founder, HemoShear.
Abel De La Rosa, Ph.D.; Chief Scientific Officer, Emory Institute for Drug Development; Drug Innovation Ventures at Emory; Emory University.
Sergio Fazio, M.D., Ph.D.; William and Sonja Connor Chair of Preventative Cardiology, Professor of Medicine and Physiology & Pharmacology; Director, Center of Preventative Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University.
Sekar Kathiresan, M.D.; Associate Professor of Medicine, Harvard Medical School; Director, Preventive Cardiology, Massachusetts General Hospital; Associate Member, Broad Institute.
Pál Maurovich-Horvat, M.D., Ph.D., M.P.H.; Heart and Vascular Center, Semmelweis University, Hungary.
Sarah S. Murray, Ph.D.; Director, Genomic Technologies, Associate Professor, Department of Pathology, Center for Advanced Laboratory Medicine, University of California San Diego.
Arshed Quyyumi, M.D., F.A.C.C., F.R.C.P.; Co-Director, Emory Clinical Cardiovascular Research Institute; Professor of Medicine, Division of Cardiology, Emory University School of Medicine.
Tim D. Spector M.B.B.S., M.D., MSc , F.R.C.P., Department of Twin Research & Genetic Epidemiology, Kings College London, St Thomas’ Hospital, London, UK.
James B. Strait, M.D., Ph.D.; Senior Medical Scientific Expert, Novartis; Cardiology Consultant, National Institute of Health (NIH).
Norman C.W. Wong, M.D., F.R.C.P.; Professor of Medicine and Biochemistry & Molecular Biology; Director, Libin Gene Therapy Unit, University of Calgary.